Veeva Systems Inc.

NYSE:VEEV

Medical - Healthcare Information Services

Healthcare
$277.20 -1.83%

-$2.83 today

Market cap
$44.88B
Beta
0.95
P/E (TTM)
26.4
EPS (TTM)
$5.76
52W Low $148.05High $310.50

Volume 2.74M

Average 3.01M

VEEV EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Veeva Systems Inc.NYSE: VEEV

EBITDA · Q2 FY2027 · quarter ended Jul 2026

EBITDA grows in line with its trailing trend

Q2 FY2027 EBITDA of $349.53M rose 26.9% year over year, ahead of the +25.9% change in trailing-twelve-month EBITDA. Sequentially, it fell 3.6% from the prior quarter. Over 3 fiscal years it compounded at +32.3% a year.

Context

  • EBITDA amounted to 39.0% of revenue in FY2026, up 4.1 pp from a year earlier.
  • EBITDA increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 21 analysts of $1.87B (+50.2%) for the fiscal year ending Jan 2027, a step up from the +29.9% reported in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJul 2026
$349.53M-3.6% QoQ
Last fiscal yearJan 2026
$1.24B+29.9% YoY
LTMJul 2026
$1.37B+25.9% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+26.9%+39.2%+12.3 pp
1 year+29.9%+50.2%+20.4 pp
3-year CAGR+32.3%+22.4%-9.8 pp
5-year CAGR+18.6%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2026
1.24B USD
Year-over-year change
+29.9%
4-year CAGR
+23.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How VEEV compares with its peers on the latest reported figures

  • VEEV's LTM Jul 2026 EBITDA of $1.37B is the 2nd highest of the 5 companies compared; the peer median is $139.75M.
  • Its year-over-year change of +25.9% is the 2nd highest of 5, against a peer median of +6.3%.
  • EBITDA amounts to 39.7% of revenue for VEEV, versus a peer median of 21.6%.
VEEV Competitors Peer median
EBITDA for VEEV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IQVIQVIA Holdings Inc.LTM Jun 2026$3.53B +5.3%+0.3%20.8%
VEEVVeeva Systems Inc.LTM Jul 2026$1.37B +25.9%+32.3%39.7%
DOCSDoximity, Inc.LTM Sep 2026$209.61M -29.4%+22.6%31.7%
HSTMHealthStream, Inc.LTM Mar 2026$69.88M +7.2%+7.6%22.4%
SDGRSchrödinger, Inc.LTM Sep 2026-$41.03M +75.6%—15.2%
Peer median (excluding VEEV) $139.75M+6.3%+7.6%21.6%

Competitors are the stored peer set for VEEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jan 2022
FY2023
Jan 2023
FY2024
Jan 2024
FY2025
Jan 2025
FY2026
Jan 2026
Revenue1.85B2.16B2.36B2.75B3.2B
Cost of Revenue503.68M609.41M677.29M699.64M782.02M
Gross Profit1.35B1.55B1.69B2.05B2.41B
Gross Margin72.8%71.7%71.3%74.5%75.5%
Research & Development382.04M520.28M629.03M693.08M767.39M
Selling, General & Admin459.57M566.29M628.02M662.47M729.54M
Operating Expenses841.6M1.09B1.26B1.36B1.5B
Depreciation & Amortization27.45M29.12M32.63M39.38M50.47M
EBITDA539.76M538.22M620.65M958.76M1.24B
EBITDA Margin29.2%25.0%26.3%34.9%39.0%
Operating Income505.5M459.09M429.33M691.44M916.37M
Operating Margin27.3%21.3%18.2%25.2%28.7%
Interest Income14.73M45.86M133.75M207.99M0
Interest Expense00000
Other Income / Expenses6.82M50.01M158.69M227.95M278.14M
Income Before Tax512.31M509.1M588.02M919.38M1.19B
Pre-Tax Margin27.7%23.6%24.9%33.5%37.4%
Income Tax Expense84.92M21.39M62.32M205.24M285.6M
Net Income427.39M487.71M525.71M714.14M908.91M
Net Margin23.1%22.6%22.2%26.0%28.4%
EPS (Basic)2.793.143.274.415.55
EPS (Diluted)2.633.003.224.325.44
Weighted Avg Shares153.25M155.39M160.53M161.88M163.67M
Weighted Avg Shares (Diluted)162.28M162.44M163.49M165.23M167M

Veeva Systems Inc.

NYSE:VEEV

Intrinsic Alpha fair value

Locked

Current Price

$277.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.